Neonatal neurobehavioral and neuroanatomic correlates of prenatal cocaine exposure. Problems of dose and confounding
- PMID: 9668396
- PMCID: PMC2423320
Neonatal neurobehavioral and neuroanatomic correlates of prenatal cocaine exposure. Problems of dose and confounding
Abstract
Complex methodologic challenges face researchers studying the effects of prenatal cocaine exposure on infant outcome. These include unavoidable imprecision in ascertaining the gestational timing and dose of cocaine to which the fetus was exposed and difficulties in identifying and quantifying the confounding, mediating, and moderating variables. Review of research on neonatal behavioral and cranial ultrasound findings following in utero cocaine exposure is used to illustrate these issues. We conclude that there are measurable but not dramatic dose-related effects of prenatal cocaine exposure on infant central nervous system structure and function. The effects of dose of prenatal cocaine exposure on later child development remain to be determined. Such research would be facilitated by a scientific consensus delineating relative doses of prenatal cocaine exposure.
References
-
- Frank DA, Bresnahan K, Zuckerman B. Advances in Pediatrics. Vol. 40. Mosby-Year Book, Inc; St. Louis, MO: 1993. Maternal cocaine use: Impact on child health and development; pp. 65–99. - PubMed
-
- Lester BM, LaGasse L, Brunner S. Data base of studies on prenatal cocaine exposure and child outcome. J. Drug Issues. 1997;27:487–499.
-
- Brazelton TB, editor. Spastics International. 2nd ed. London, England: 1984. Neonatal Behavioral Assessment Scale.
-
- Scafidi FA, Field TM, Wheeden A, et al. Cocaine-exposed preterm neonates show behavioral hormonal differences. Pediatrics. 1996;97:851–855. - PubMed
-
- Richardson GA, Hamel SC, Goldschmidt L, Day NL. The effects of prenatal cocaine use on neonatal neurobehavioral status. Neurotoxicol. Teratol. 1993;18:519–528. - PubMed
